Raphael Pharmaceutical Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $208.0K | $50.0K |
| FY2020 | — | $-43.0K | $95.0K |
| FY2021 | — | $128.0K | $153.0K |
| FY2022 | — | $106.0K | $288.0K |
| FY2023 | — | $107.0K | $230.0K |
| FY2024 | — | $-742.0K | $19.0K |
| FY2025 | — | $-1.4M | $45.0K |